Nanovaccine for leishmaniasis: preparation of chitosan nanoparticles containing Leishmania superoxide dismutase and evaluation of its immunogenicity in BALB/c mice

BACKGROUND: Leishmaniasis is a protozoan disease, affecting 12 million people in different regions of the world with a wide spectrum of diseases. Although several chemotherapeutic agents have been used for treating the disease, long-term therapy, limited efficacy and the development of drug-resistan...

Full description

Saved in:
Bibliographic Details
Main Authors: Danesh-Bahreini, Mohammad Ali, Shokri, Javad, Samiei, Afshin, Kamali-Sarvestani, Eskandar, Barzegar-Jalali, Mohammad, Mohammadi-Samani, Soliman
Format: Artigo
Language:Inglês
Published: Dove Medical Press 2011
Subjects:
Original Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3090280/
https://ncbi.nlm.nih.gov/pubmed/21589651
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S16805
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items